Homburger advised Avolta on the issuance of EUR 500 m Bonds
On April 18, 2024, Dufry One B.V. issued EUR 500 m Bonds guaranteed by Avolta AG and certain of its subsidiaries.
Homburger advised DWS on Crypto ETPs
On March 27, 2024, Swiss special purpose issuance vehicle Xtrackers Digital Markets ETC AG simultaneously launched two series of crypto-linked Exchange Traded Products (ETPs) under its program for the issuance of cryptocurrency-focused ETPs for professional and retail investors in Europe.
Homburger advised Meyer Burger on its CHF 206.75 m rights offering
On April 3, 2024, Meyer Burger Technology AG (SIX: MBTN) announced the successful completion of its rights offering, raising gross proceeds of CHF 206.75 m. Shares not subscribed by shareholders were placed with institutional investors at the prevailing market price.
Homburger advised Addex Therapeutics Ltd (SIX and Nasdaq: ADXN) on the launch of Neurosterix
On April 3, 2024, Addex Therapeutics, a clinical-stage biopharmaceutical company,
Homburger advised Stiftung PWG on its issuance of CHF 120 m total nominal amount of 1.55% Sustainability Bonds 2024-2032
On March 20, 2024, Stiftung PWG zur Erhaltung von preisgünstigen Wohn- und Gewerberäumen der Stadt Zürich (Stiftung PWG), successfully launched and priced its issuance of CHF 120 m total nominal amount of 1.55% Sustainability Bonds 2024-2032.
Homburger advised Nestlé on the issuance of an aggregate of USD 2.5 bn notes through an institutional (Rule 144A) offering in the United States of America
On March 12, 2024, Nestlé Capital Corporation successfully completed its issuance of USD 600 m 4.650% Notes due 2029, USD 450 m 4.750% Notes due 2031, USD 800 m 4.875% Notes due 2034, and USD 650 m 5.100% Notes due 2054.
Homburger advised Roche on USD 3.875 bn in aggregate principal amount senior notes, which were issued by Roche Holdings, Inc. and guaranteed by Roche Holding Ltd
On March 8, 2024, Roche Holdings, Inc. successfully completed its issuance of USD 3.875 bn in aggregate principal amount of senior notes,
Homburger advised Swiss Prime Site on its acquisition of Fundamenta Group’s real estate division
Homburger advised Swiss Prime Site AG (SPS), the largest real estate company in Switzerland (SWX: SPSN), on the acquisition of Fundamenta Group’s real estate division.
Homburger advises Galderma on its IPO on SIX Swiss Exchange
On March 13, 2024, Galderma Group AG (Galderma), the pure-play dermatology category leader, announced the launch of its Initial Public Offering (Offering) on the SIX Swiss Exchange.
Homburger advised Thermo Fisher on its CHF 1.070 bn inaugural bond issuance
On March 7, 2024, Thermo Fisher Scientific Inc. successfully completed its issuance of its inaugural CHF bonds in excess of CHF 1 bn, being the largest foreign Swiss franc bond issuance in seven years.